RSS   Newsletter   Contact   Advertise with us
Post Online Media

Amarin appoints Michael W. Kalb as CFO

Amarin CorporationAmarin Corporation, a biotechnology company, announced that Michael W. Kalb has joined its senior management team as senior vice president and chief financial officer.
Article continues below

READ MORE Amarin appoints Colin W. Stewart as president and CEO

Mr. Kalb brings over 20 years of international financial operations and accounting advisory experience.

Mr. Kalb joins Amarin from Taro Pharmaceutical Industries, Ltd., a publicly-traded, multinational, science-based pharmaceutical company where he served as chief financial officer and chief accounting officer.

Prior to joining Taro, he was a director in the Accounting and Financial Consulting Group of Huron Consulting Group.

Mr. Kalb's experience also includes over ten years at Ernst & Young, LLP within its Transaction Advisory Services Group and Audit and Assurance Services Group. He is a certified public accountant.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy